ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The quest for biomarkers in tuberculosis

Parida, Shreemanta K.*; Kaufmann, Stefan H. E.
Drug Discovery Today2010-2DOI: 10.1016/j.drudis.2009.10.005
90被引2阅读
引用收藏
分享

摘要

No new vaccine has been licensed for tuberculosis (TB) for more than three-quarters of a century, and no new drug has been licensed for half a century. One major drawback has been the attrition caused by the lack of a reliable biological indicator (biomarker) to predict toxicity and efficacy early in the development pipeline. This review portrays the landscape of biomarker discovery for TB in the context of drug and vaccine development using emerging global biomics platforms. The time is ripe to move from single markers for correlates of protection to a biosignature comprising a well-defined set of robust indicators in TB that can accelerate rapid screening and early selection of potential drug and vaccine candidates.

学科与关键词

关键词
COMPARATIVE PROTEOME ANALYSISMYCOBACTERIUM-TUBERCULOSIST-CELLPULMONARY TUBERCULOSISIMMUNE RECONSTITUTIONSYSTEMS BIOLOGYBCG VACCINATIONINFECTIONANTIGENSRESPONSES
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Drug Discovery Today
发表日期
2010-02
卷期
第 15 卷, 第 3-4 期
页码
148-157
DOI
10.1016/j.drudis.2009.10.005
语言
ENGLISH
成果收录
SCIE
资助标注
Bill & Melinda Gates Foundation Grand Challeges in Global Health [37772]; European Union; Design and Testing of Vaccine Candidates against Tuberculosis; Bundesministerium fur Bildung und Forschung Networks PathoGenoMikPlus and Nationales Genomforschungsnetz

作者

  • P

    Parida, Shreemanta K. (通讯) (第一作者)

  • K

    Kaufmann, Stefan H. E.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417